Datix appoints Dr Daniel Cohen as International Medical Director
Posted By Editor on April 4, 2011
We are pleased to announce the appointment of Dr Daniel L Cohen as International Medical Director. Prior to Datix, Dr Cohen was Chief Medical Officer and Executive Medical Director for the United States Department of Defense (DoD) health plan, which now provides healthcare services for over 9.4 million beneficiaries worldwide with a budget exceeding US $45 billion. During his time at the DOD, Dr Cohen provided senior level counsel for the organisation’s patient safety, clinical quality assessment, population health and medical management programmes.
During his distinguished career, Dr Cohen has held senior appointments at some of the world’s most prestigious academic institutions including the University of Cambridge and the Harvard Medical School. He is also a senior partner in the prominent US consulting firm Martin, Blanck & Associates, a leading healthcare advisory organisation that consists of individuals with extensive senior executive expertise as administrators, policy makers, clinicians and scientists.
Dr Cohen commented, “Datix has a well-earned reputation for developing best-in-class software and delivering excellent customer service. The next step is to utilise the energy and talent within Datix to transform the organisation into a real driving force in improving safety and quality of care internationally. I have joined Datix at an exciting time and look forward to helping this team tap into its full potential.”
Jonathan Hazan, Chief Executive of Datix, added, “We are honoured to have Dr Cohen join us. As a seasoned healthcare practitioner and consultant, he brings with him an unrivalled knowledge and experience of the patient safety market that will be invaluable to us. I am confident that his expertise and knowledge will further enhance our international status and help drive our organisation forward.“
Dr Cohen was initially trained in paediatrics and haematology/oncology at the Boston Medical Center, Boston University, and the Boston Children’s Hospital, Dana Farber Cancer Institute, Harvard Medical School. He is a Senior Fellow of the Royal College of Paediatrics and Child Health and a Fellow of the American Academy of Pediatrics.
Comments